psihiatru
ro
cercetare
Bibliografie
1. Vartiainen E., Jousilahti P., Alfthan G., Sundvall J., Pietinen P., Puska 19. Kivipelto M., Ngandu T., Fratiglioni L., Viitanen M., Kåreholt I.,
P. Cardiovascular risk factor changes in Finland, 1972-1997. Interna- Winblad B., Helkala E.L., Tuomilehto J., Soininen H., Nissinen A.
tional Journal of Epidemiology 2000; 29:4-56. Obesity and vascular risk factors at midlife and the risk of dementia
2. Kivipelto M., Helkala E.L., Laakso M.P., Hanninen T., Hallikainen M., and Alzheimer’s disease. Arch Neurol 2005; 62: 1.556-1.560.
Alhainen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular 20. Luchsinger J.A. and Mayeux R. Dietary factors and AD. Lancet Neu-
risk factors and Alzheimer’s disease in later life: longitudinal, popu- rology 2004.
lation based study. BMJ 2001; 322(7300):1.447-51. 21. Laitinen M., Ngandu T., Rovio S. et al. Fat Intake at Midlife and Risk
3. Launer L.J., Ross G.W., Petrovitch H., Masaki K., Foley D., White L.R., of Dementia and Alzheimer’s Disease: A Population-based Study.
Havlik R.J. Midlife blood pressure and dementia: the Honolulu-Asia Dement Ger Cogn Disord 2006; 22:99-107.
aging study. Neurobiol Aging 2000; 21:49-55. 22. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., Rostaing
4. Kivipelto M., Helkala E.L., Laakso M.P., Hänninen T., Hallikainen M., P., Triller A., Salem N. Jr., Ashe K.H., Frautschy S.A., Cole G.M. Doco-
Alhainen K., Iivonen S., Mannermaa A., Tuomilehto J., Nissinen A., sahexaenoic acid protects from dendritic pathology in an Alzheim-
Soininen H. Apolipoprotein E β4 allele, elevated midlife total choles- er’s disease mouse model. Neuron. 2004; 43(5):633-45
terol level and high midlife systolic blood pressure are independent 23. Oksman M., Iivonen H., Hogyes E., Amtul Z., Penke B., Leenders I.,
risk factors for late-life Alzheimer’s disease. Annals of Internal Medi- Broersen L., Lutjohann D., Hartmann T., Tanila H. Impact of differ-
cine 2002; 137:149-155. ent saturated fatty acid, polyunsaturated fatty acid and cholesterol
5. Skoog I., Lernfelt B., Landahl S. et al. 15-year longitudinal study of containing diets on beta-amyloid accumulation in APP/PS1 trans-
blood pressure and dementia. Lancet 1996; 347:1.141-1.145. genic mice. Neurobiol Dis. 2006; 23(3):563-72.
6. Peila R., White L.R., Masaki K., Petrovitch H., Launer L.J. Reducing 24. Freund-Levi Y., Eriksdotter-Jonhagen M., Cederholm T., Basun H.,
the risk of dementia: efficacy of long-term treatment of hyperten- Faxen-Irving G., Garlind A., Vedin I., Vessby B., Wahlund L.O., Palm-
sion. Stroke 2006;37(5): 1.165-70. blad J. Omega-3 fatty acid treatment in 174 patients with mild to
7. Whitmer R.A., Sidney S., Selby J., Johnston S.C. Yaffe K. Midlife car- moderate Alzheimer disease: OmegAD study: a randomized double-
diovascular risk factors and risk of dementia in late life. Neurology. blind trial. Arch Neurol. 2006; 63(10):1.402-8.
2005; 64(2): 277-81. 25. Scarmeas N., Stern Y., Mayeux R., Luchsinger J.A. Mediterranean
8. Launer L.J., White L.R., Petrovitch H., Ross G.W., Curb J.D. Cholester- diet, Alzheimer disease, and vascular mediation. Arch Neurol. 2006;
ol and neuropathologic markers of AD: a population-based autopsy 63(12):1.709-17.
study. Neurology. 2001; 57:1.447-52. 26. Fratiglioni L., Paillard-Borg S., Winblad B. An active and socially in-
9. Pappolla M.A., Bryant-Thomas T.K., Herbert D., Pacheco J., Fabra tegrated lifestyle in late life might protect against dementia. Lancet
Garcia M., Manjon M., Girones X., Henry T.L., Matsubara E., Zam- Neurol. 2004; 3(6): 343-53.
bon D., Wolozin B., Sano M., Cruz-Sanchez F.F., Thal L.J., Petanceska 27. Rovio S., Kåreholt I., Helkala E.L. et al. Leisure Time Physical Ac-
S.S., Refolo L.M. Mild hypercholesterolemia is an early risk factor for tivity at Midlife and the Risk of Dementia and Alzheimer’s Disease.
the development of Alzheimer amyloid pathology. Neurology. 2003; Lancet Neurol 2005; 4:705-710.
61(2):199-205. 28. Colcombe S.J., Kramer A.F., Erickson K.I. et al. Cardiovascular fit-
10. Solomon A., Kåreholt I., Ngandu T., Winbald B., Nissinen A., Tu- ness, cortical plasticity, and aging. Proc Natl Acad Sci USA 2004;
omilehto J., Soininen H., Kivipelto M. (2007). Serum cholesterol 101(9):3.316-3.321.
changes after midlife and late-life cognition: 21-year follow-up 29. Berchtold N.C., Kesslak J.P., Cotman C.W. Hippocampal brain-de-
study. Neurology; 68(10):751-6. rived neurotrophic factor gene regulation by exercise and the me-
11. Solomon A., Kåreholt I., Ngandu T., Wolozin B., MacDonald S.W.S., dial septum. J Neurosci Res 2002; 68:511-521.
Winblad B., Nissinen A., Tuomilehto J., Soininen H., Kivipelto M. 30. Tong L., Shen H., Perreau V.M., Balazs R., Cotman C.W. Effects of
Serum total cholesterol, statins and cognition in non-demented exercise on gene-expression profile in the rat hippocampus. Neuro-
elderly. Neurobiol Aging, in press. biol Dis 2001; 8:1.046-1.056.
12. Stewart R., White L.R., Xue Q.L., Launer L.J. Twenty-six-year change 31. Kramer A., Hahn S., Cohen N.J. et al. Ageing, fitness and neurocog-
in total cholesterol levels and incident dementia: the Honolulu-Asia nitive function. Nature 1999; 400:418-419.
Aging Study. Arch Neurol. 2007; 64(1):103-7. 32. Mukamal K.J., Longstreth W.T. Jr., Mittleman M.A., Crum R.M.,
13. Björhem I. Crossing the barrier: oxysterlos as cholesterol transporters Siscovick D.S. Alcohol consumption and subclinical findings on
and metabolic modulators in the brain. J Int Med 2006; 260: 493-508. magnetic resonance imaging of the brain in older adults: the cardio-
14. Sparks D.L., Scheff S.W., Hunsaker J.C. 3rd, Liu H., Landers T., Gross vascular health study. Stroke 2001; 32(9):1.939-46.
D.R. Induction of Alzheimer-like beta-amyloid immunoreactivity 33. Ding J., Eigenbrodt M.L., Mosley T.H. Jr., Hutchinson R.G., Folsom
in the brains of rabbits with dietary cholesterol. Exp Neurol. 1994; A.R., Harris T.B., Nieto F.J. Alcohol intake and cerebral abnormalities
126(1):88-94. on magnetic resonance imaging in a community-based population
15. Rockwood K. Epidemiological and clinical trials evidence about a of middle-aged adults: the Atherosclerosis Risk in Communities
preventive role for statins in Alzheimer's disease. Acta Neurol Scand (ARIC) study. Stroke 2004; 35(1):16-21.
Suppl. 2006; 185: 71-7. 34. Cedazo-Minguez A., Cowburn R.F. Apolipoprotein E: a major piece
16. Simons M., Schwarzler F., Lutjohann D., von Bergmann K., in the Alzheimer’s disease puzzle. J Cell Mol Med 2001; 5:254-266.
Beyreuther K., Dichgans J., Wormstall H., Hartmann T., Schulz J.B. 35. Brookmeyer R., Gray S., Kawas C. Projections of Alzheimer’s dis-
Treatment with simvastatin in normocholesterolemic patients with ease in the United States and the public health impact of delaying
Alzheimer’s disease: A 26-week randomized, placebo-controlled, disease onset. Am J Public Health. 1998; 88(9):1.337-42.
double-blind trial. Ann Neurol. 2002; 52:346-50. 36. Kivipelto M., Ngandu T., Laatikainen T., Winblad B., Soininen H.,
17. Sparks D.L., Sabbagh M.N., Connor D.J., Lopez J., Launer L.J., Tuomilehto J. Risk Score for prediction of dementia risk in 20 years
Browne P., Wasser D., Johnson-Traver S., Lochhead J., Ziolwolski C. among middle aged people: a longitudinal population based study.
Atorvastatin for the treatment of mild to moderate Alzheimer dis- Lancet Neurology 2006; 9:735-41.
ease: preliminary results. Arch Neurol. 2005; 62:753-7. 37. Whitmer R.A., Barnes D., Kivipelto M., Quesenberry C.P., Ngandu
18. Gustafson D., Rothenberg E., Blennow K., Steen B., Skoog I. An 18- T., Yaffe K. A midlife risk score for the prediction of dementia more
year follow-up of overweight and risk of Alzheimer disease. Arch than three decades later. Alzheimer’s and dementia 2007; 3(3) Suppl
Intern Med 2003;163:1.524-8. 2, O1-02-06, S170.
pag. 50
Nr. 11/decembrie 2007
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68